Acorda Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
23 Jun 2023	Form 4: Burns Thomas M., Director Granted 2,400 Non-Employee Stock Option
23 Jun 2023	Form 4: Varian John, Director Granted 1,200 Non-Employee Stock Option
23 Jun 2023	Form 4: Panem Sandra Phd, Director Granted 1,200 Non-Employee Stock Option
23 Jun 2023	Form 4: Kelley John P, Director Granted 1,200 Non-Employee Stock Option
23 Jun 2023	Form 4: Jensen Peder, Director Granted 1,200 Non-Employee Stock Option
04 Apr 2023	Form 4: Cohen Ron, Director Granted 168,800 Employee Stock Option (right to buy)
04 Apr 2023	Form 4: Clem Kerry M, Chief Commercial Officer Granted 77,300 Employee Stock Option (right to buy)
04 Apr 2023	Form 4: Belloff Neil S., General Counsel and Corp Secy Granted 77,300 Employee Stock Option (right to buy)
20 Mar 2023	Form 4: Cohen Ron, Director Bought 10,156 shares ($6.09K) · Bought 10,000 shares ($6.5K)
04 Jan 2023	Form 4: Varian John, Director Granted 4,712 Non-Employee Stock Option
07 Sep 2022	Form 4: Sabella Lauren M, Chief Operating Officer Gave up 1,511 shares to cover exercise price or tax ($601)
07 Sep 2022	Form 4: Clem Kerry M, Chief Commercial Officer Gave up 1,511 shares to cover exercise price or tax ($601)
14 Jun 2022	Form 4: Randall Lorin, Director Granted 10,000 Non-Employee Stock Option
14 Jun 2022	Form 4: Panem Sandra Phd, Director Granted 10,000 Non-Employee Stock Option
14 Jun 2022	Form 4: Kelley John P, Director Granted 10,000 Non-Employee Stock Option
14 Jun 2022	Form 4: Jensen Peder, Director Granted 10,000 Non-Employee Stock Option
21 Mar 2022	Form 4: Cohen Ron, Director Sold 2,289 shares ($3.89K)
04 Jan 2022	Form 4: Varian John, Director Granted 20,000 Non-Employee Stock Option
15 Nov 2021	Form 4: Cohen Ron, Director Granted 100,000 Employee Stock Option (right to buy)
09 Nov 2021	Form 4: Gesser Michael A, Chief Financial Officer Granted 85,000 Employee Stock Option (right to buy)

Comments